EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression

• Published in: Blood 2007-06, Vol.109 (12), p.5191-5198
• Main Authors: Wagner, Lori A., Christensen, Clarissa J., Dunn, Diane M., Spangrude, Gerald J., Georgelas, Ann, Kelley, Linda, Esplin, M. Sean, Weiss, Robert B., Gleich, Gerald J.
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Cells, Cultured; Eosinophil Granule Proteins - genetics; Eosinophil Major Basic Protein - genetics; Eosinophil-Derived Neurotoxin - genetics; Eosinophils - metabolism; Gene Expression Profiling; Gene Expression Regulation - genetics; Hematologic and hematopoietic diseases; Hematopoiesis; Hematopoietic Stem Cells - metabolism; Humans; Inositol 1,4,5-Trisphosphate Receptors - genetics; Medical sciences; RNA, Untranslated - genetics; RNA, Untranslated - physiology; Transcription, Genetic
• ISSN: 0006-4971; 1528-0020
• DOI: 10.1182/blood-2006-06-027987

Gene expression profiling of early eosinophil development shows increased transcript levels of proinflammatory cytokines, chemokines, transcription factors, and a novel gene, EGO (eosinophil granule ontogeny). EGO is nested within an intron of the inositol triphosphate receptor type 1 (ITPR1) gene and is conserved at the nucleotide level; however, the largest open reading frame (ORF) is 86 amino acids. Sucrose density gradients show that EGO is not associated with ribosomes and therefore is a noncoding RNA (ncRNA). EGO transcript levels rapidly increase following interleukin-5 (IL-5) stimulation of CD34+ hematopoietic progenitors. EGO RNA also is highly expressed in human bone marrow and in mature eosinophils. RNA silencing of EGO results in decreased major basic protein (MBP) and eosinophil derived neurotoxin (EDN) mRNA expression in developing CD34+ hematopoietic progenitors in vitro and in a CD34+ cell line model. Therefore, EGO is a novel ncRNA gene expressed during eosinophil development and is necessary for normal MBP and EDN transcript expression.